These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5726165)

  • 1. Microbial content of nonsterile therapeutic agents containing natural of seminatural active ingredients.
    Schiller I; Kuntscher H; Wolff A; Nekola M
    Appl Microbiol; 1968 Dec; 16(12):1924-8. PubMed ID: 5726165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method for microbiological testing of nonsterile pharmaceuticals.
    Bühlmann X
    Appl Microbiol; 1968 Dec; 16(12):1919-23. PubMed ID: 5726164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles].
    Witschi T
    Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309
    [No Abstract]   [Full Text] [Related]  

  • 4. [Scientific claims regarding sterile preparations].
    Speiser P
    Pharm Acta Helv; 1973 Feb; 48(2):63-82. PubMed ID: 4706310
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent aspects of the microbiological contamination of pharmaceutical products and their microbiological specification (author's transl)].
    Kurata H; Ishizeki C; Udagawa S
    Eisei Shikenjo Hokoku; 1978; (96):1-26. PubMed ID: 373832
    [No Abstract]   [Full Text] [Related]  

  • 6. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Production in middle size plants].
    Bucher K
    Pharm Acta Helv; 1973 Feb; 48(2):101-16. PubMed ID: 4706308
    [No Abstract]   [Full Text] [Related]  

  • 7. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Production in bigger plants].
    Schnorf U
    Pharm Acta Helv; 1973 Feb; 48(2):83-100. PubMed ID: 4706311
    [No Abstract]   [Full Text] [Related]  

  • 8. [Microbial contamination of some non-injection drug preparations].
    Berezovskaia IV
    Farmatsiia; 1976; 25(2):74-8. PubMed ID: 1269795
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the sterilization of pharmaceutical base materials with ionizing radiation and ethylene oxide.
    Woźniak-Parnowska W; Najer A
    Acta Microbiol Pol; 1978; 27(2):161-8. PubMed ID: 80929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiological purity of pharmaceutical forms non-necessarily sterile].
    J Pharm Belg; 1972; 27(6):670-82. PubMed ID: 4665014
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural product source material use in the pharmaceutical industry: the Glaxo experience.
    Turner DM
    J Ethnopharmacol; 1996 Apr; 51(1-3):39-43; discussion 44. PubMed ID: 9213629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological control in the manufacture of sterile pharmaceutical products.
    Bühlmann X
    Pharm Acta Helv; 1971 Jul; 46(7):385-409. PubMed ID: 4934853
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural products research: perspectives from a major pharmaceutical company.
    Borris RP
    J Ethnopharmacol; 1996 Apr; 51(1-3):29-38. PubMed ID: 9213624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug analysis and pharmakopoea, a critical survey (author's transl)].
    Wichtl M
    Planta Med; 1978 Sep; 34(2):113-28. PubMed ID: 360255
    [No Abstract]   [Full Text] [Related]  

  • 15. Fidelity to Science & Correct Scientific Vocabulary-Microbial Control Versus Contamination Control.
    Tidswell EC; Tirumalai R; Hussong D
    PDA J Pharm Sci Technol; 2019; 73(5):510-516. PubMed ID: 31101705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aseptic process monitoring--a better strategy. Validation Group, Inc.
    Wilson JD
    PDA J Pharm Sci Technol; 1999; 53(3):111-4. PubMed ID: 10754699
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventing Cross-Contamination during Lyophilization: GMP and Occupational Cleaning Requirements for Nonproduct and Indirect Product-Contact Parts.
    Denk R; Flückiger A; Kisaka H; Krause S; Maeck R; Restetzki L; Schreiner A; Schulze R
    PDA J Pharm Sci Technol; 2019; 73(5):487-495. PubMed ID: 31420508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality Control: microbial limit tests for nonsterile pharmaceuticals, part 2.
    Vu N; Lou JR; Kupiec TC
    Int J Pharm Compd; 2014; 18(4):305-10. PubMed ID: 25474859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleaning Validation: Complete Guide for Health - Based Approach in Chemical Cross - Contamination Risk Assessment.
    Tanyous JN
    PDA J Pharm Sci Technol; 2019; 73(2):204-210. PubMed ID: 30361288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacognostic studies of digitalis conducted by William Withering and his role in the development of digitalis preparations].
    Krysa-Leszczyńska D; Szczytnicka H
    Wiad Lek; 1988 Oct; 41(19):1325-9. PubMed ID: 3073586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.